In vivo inhibition of Pim1/2-mediated BAD protein phosphorylation at Ser-112 in human KMS-12-BM cells xenografted in SCID-beige mouse measured after 6 to 16 hrs by meso scale discovery assay
In vivo inhibition of Pim1/2-mediated BAD protein phosphorylation at Ser-112 in human KMS-12-BM cells xenografted in SCID-beige mouse assessed as pBAD level at 25 mg/kg, po administered as single dose measured after 6 hrs by meso scale discovery assay
In vivo inhibition of Pim1/2-mediated BAD protein phosphorylation at Ser-112 in human KMS-12-BM cells xenografted in SCID-beige mouse assessed as pBAD level at 50 mg/kg, po administered as single dose measured after 6 hrs by meso scale discovery assay
In vivo inhibition of Pim1/2-mediated BAD protein phosphorylation at Ser-112 in human KMS-12-BM cells xenografted in SCID-beige mouse assessed as pBAD level at 100 mg/kg, po administered as single dose measured after 6 hrs by meso scale discovery assay
In vivo inhibition of Pim1/2-mediated BAD protein phosphorylation at Ser-112 in human KMS-12-BM cells xenografted in SCID-beige mouse assessed as pBAD level at 25 mg/kg, po administered as single dose measured after 16 hrs by meso scale discovery assay
In vivo inhibition of Pim1/2-mediated BAD protein phosphorylation at Ser-112 in human KMS-12-BM cells xenografted in SCID-beige mouse assessed as pBAD level at 50 mg/kg, po administered as single dose measured after 16 hrs by meso scale discovery assay
In vivo inhibition of Pim1/2-mediated BAD protein phosphorylation at Ser-112 in human KMS-12-BM cells xenografted in SCID-beige mouse assessed as pBAD level at 100 mg/kg, po administered as single dose measured after 16 hrs by meso scale discovery assay